SPY395.86+1.97 0.50%
DIA320.31+0.92 0.29%
IXIC11,360.75+96.30 0.85%

BRIEF-Biocytogen Enters into Antibody Agreement with Merck

reuters.com · 04/29/2022 08:08
BRIEF-Biocytogen Enters into Antibody Agreement with Merck

- Merck & Co Inc MRK:

  • BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. - ENTERED INTO EVALUATION AND OPTION AGREEMENT WITH MERCK

Source text for Eikon: ID:nPreWbNVqa

Further company coverage: MRK


((Reuters.Briefs@thomsonreuters.com;))